Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-397P is a *pseudogene*—a non-coding genomic sequence similar in structure and sequence to the functional U6 small nuclear RNA gene, but lacking biological activity due to disablements such as mutations, deletions, or rearrangements. Functional U6 snRNA is highly conserved, plays a central role in spliceosome-mediated pre-mRNA splicing, and is structurally essential for forming the catalytic core of the spliceosome[1][3]. Pseudogenes like RNU6-397P result from genomic duplication and subsequent loss of function, and while they are prevalent in vertebrate genomes, they do not encode active RNA nor participate directly in splicing. The functional gene is vital for cell viability; however, RNU6-397P, as a pseudogene, is biologically inert and often regarded as genomic "fossil records" rather than active targets[6][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 397, pseudogene (RNU6-397P).